DIA and RAPS are excited to once again jointly produce 2027 Combination Products in the EU, a summit convening 26–27 January at the Radisson Grand Place in Brussels, Belgium. This highly-interactive event will unite key stakeholders across the field—including representatives from EMA, the European Commission, Notified Bodies, National Competent Authorities and Industry—to explore a coordinated drug and device approach to incentivise competitive innovation in Europe.
Throughout the summit, experts will exchange ideas via action-oriented working groups that stimulate ideation and innovation around designing solutions for pragmatic implementation.
Don’t forget to arrive early to join us for a special preconference workshop on 25 January focused on Introduction to Combination Products in the EU: Regulatory and Practical Insights (separate fee required).
2026 by the Numbers
An impressive initiative by the organizers to bring together all parties involved in in-vitro diagnostics and medical devices for decision-making, resulting in an exceptionally focused group.
Addressing Vital Topics to Drive EU Innovation
By exploring current challenges and opportunities to unite for better pathways forward, the programme will highlight critical topics such as:
- The changing EU regulatory landscape
- EU AI Act
- COMBINE
- Platform technologies
- Cybersecurity
- Home-use and self-administration
- And so much more!
I can't think of a better place to learn from all key stakeholders the latest developments in this important and highly dynamic area of regulatory affairs.
Are you a current RAC holder?
Attend 2027 Combination Products in the EU and earn 12.0 RAC recertification credits.
Sponsorships
Packages are now available to support the 2027 Combination Products in the EU, presented by DIA and RAPS. Learn more by contacting David Kurywchak.
David Kurywchak
Director, Business Development & Sales
Email: [email protected]
Phone: +1 301 770 2920 X246
Event Hosts
DIA is a leading global life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.
Learn more at DIAglobal.org, and connect with DIA on LinkedIn, Facebook, X (Twitter), and Instagram.
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of professionals involved with regulatory and quality for healthcare products, including medical devices, pharmaceuticals and biologics, diagnostics, and digital health. Founded in 1976 as a neutral, nonprofit organization, RAPS supports and elevates the regulatory profession with education and training, professional standards, publications, research, networking, career development, and other valuable resources. RAPS is home to the Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. The society is headquartered in suburban Washington, D.C., with chapters and affiliates worldwide. www.raps.org